Stance Capital’s Crocs CROX Stock Holding History

Stance Capital’s Portfolio CROX Stock Details CROX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-600	Closed	-$49.8K	–	358
2026 Q1	$49.8K	Buy	+600	New	+$51.4K	0.02%	138

Other funds holding CROX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Stance Capital's CROX Position: Q2 2026 in Review

Stance Capital sold out of Crocs (CROX) in Q2 2026, closing a stake of 600 shares — an estimated $49.8K sold.

Stance Capital first reported a position in CROX in Q1 2026 and held it in 1 quarter. The position peaked at $49.8K in Q1 2026. 502 funds tracked by Wall St. Rank hold CROX as of Q2 2026.

Stance Capital reported no remaining Crocs position as of Q2 2026 after selling out during the quarter.
Stance Capital sold 600 Crocs shares in Q2 2026, an estimated $49.8K.
Stance Capital first reported a position in Crocs in Q1 2026 and held it in 1 quarter.
Stance Capital's Crocs position peaked at $49.8K in Q1 2026.
502 funds tracked by Wall St. Rank held Crocs as of Q2 2026.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.